The Global Wireless Device to Monitor Lung Sound Market Size was valued at USD 5,933 Million in 2021 and is anticipated to reach USD 10,297 Million by 2030 with a CAGR of 6.3% from 2022 to 2030.

Healthcare is one of the many areas of our daily lives that technology and advancements in artificial intelligence have significantly altered over the past several decades. Wearables, smart inhalers, digital stethoscopes, portable electronic spirometers, and clinical decision support systems are just a few examples of the many subdomains that fall under the umbrella of e-health. E-health has repeatedly been demonstrated to improve treatment quality, increase adherence to medication, and enable early diagnosis of deterioration in chronic pulmonary diseases.

Market Dynamics

The major causes of death and disability worldwide are respiratory disorders. The respiratory system is also being impacted by the current COVID-19 outbreak. Medical personnel and the clinical setting are required for the detection and diagnosis of respiratory illnesses. The majority of current procedures were either costly or intrusive. Some research teams are creating hardware and software that will enable the acquisition of respiratory sounds remotely or even non-invasively. Following that, these sounds are processed and analyzed for therapeutic, research, or educational purposes.

The world's top killers and disablers, particularly in industrialized nations, are respiratory disorders like asthma and Chronic Obstructive Pulmonary Disease (COPD). The most prevalent respiratory ailment is asthma. It affects 235 million people worldwide, and it is particularly prevalent in children. 3 million people every year pass away from COPD, which affects 65 million people worldwide. Other conditions that impact humans include chronic bronchitis, lung cancer, and pneumonia. Acute lower respiratory infections (ALRI) cause more deaths in children under five than malaria, very high fever (VHI), and tuberculosis combined. Another illness that affects the respiratory system and is creating a wide range of issues is COVID-19 infection.

Rising number of lung sound devices and increased FDA clearance is expected to boost the global wireless device to monitor lung sound market. For its Remote E-Stethoscope Platform (RESP), a device for measuring, recording, and analysing lung sounds remotely across healthcare settings; Strados Labs has gained FDA authorization.

The RESP system has reportedly been utilized by the firm in clinical trials to assist researchers in quantifying changes in lung sounds over time for comparison with therapies, patient-reported outcomes, and other vital indicators. With the help of a small, wearable sensor, a cloud-based software platform, and HIPAA-compliant software, the RESP may remotely record, store, and make changes in a patient's lung sounds available for clinical study.

Market Insights

The three categories of the global wireless device to monitor lung sound market are technology, device display, end-user, and region. Technology segment can be further divided into diagnostic ultrasound (3D & 4D Ultrasound and Doppler Ultrasound), therapeutic ultrasound (High Intensity Focused Ultrasound (HIFU) and Extracorporeal Shockwave Lithotripsy (ESWL)). Among them, the diagnostic ultrasound sub-segment generated the largest market shares in 2021. The enormous utility of 2D ultrasound, the availability of medical reimbursement schemes, ongoing technological breakthroughs in the area of diagnostic ultrasound imaging, and the explosion in applications of developing ultrasound techniques are all credited with the greatest share of this market. Based on device display, the segmentation includes Color Ultrasound and B/W Ultrasound. Furthermore, end-user sub-segment is split into hospitals, surgical centers, diagnostic centers, ambulatory surgical centers, research and academia, and others.

Global Wireless Device to Monitor Lung Sound Market Geographical Competition

The North American, European, Latin American, Asian Pacific, and Middle Eastern & African regions make up the five geographical segments of the worldwide wireless device to monitor lung sound market. In the global market for wireless devices to monitor lung sounds, North America held the biggest market share. Due to the vast population of patients with lung disorders, there is a great demand for wireless devices to monitor lung sound. According to the Centers for Disease Control and Prevention (CDC), there were 9.0 million adults in the US with chronic bronchitis, or roughly 3.6% of adults. Despite the fact that the illness continues to be the top reason for cancer deaths in both women and men, the survival rate has dramatically increased in recent years, rising from 22.6% to 13%.

Global Wireless Device to Monitor Lung Sound Industry Segment Analysis

Wireless Device to Monitor Lung Sound Market By Technology

• Therapeutic Ultrasound
• High Intensity Focused Ultrasound (HIFU)
• Extracorporeal Shockwave Lithotripsy (ESWL)
• Diagnostic Ultrasound
• 3D & 4D Ultrasound
• Doppler Ultrasound

Wireless Device to Monitor Lung Sound Market By Device Display

• B/W Ultrasound
• Color Ultrasound

Wireless Device to Monitor Lung Sound Market By End-User

• Diagnostic Centers
• Hospitals
• Ambulatory Surgical Centers
• Surgical Centers
• Research And Academia
• Others

Wireless Device to Monitor Lung Sound Market Leading Companies

This section of the study honors the market's top vendors Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., Samsung Electronics, Ltd., and Siemens Healthineers AG. Other players involve Analogic Corporation, Carestream, Chison Medical Imaging, Esaote S.p.A., Hologic, Mindray Medical International Ltd., Mobisante, and Shimadzu Corporation.

Wireless Device to Monitor Lung Sound Market Regions